1. Home
  2. ARVN vs CLW Comparison

ARVN vs CLW Comparison

Compare ARVN & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • CLW
  • Stock Information
  • Founded
  • ARVN 2015
  • CLW 2005
  • Country
  • ARVN United States
  • CLW United States
  • Employees
  • ARVN N/A
  • CLW N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • CLW Paper
  • Sector
  • ARVN Health Care
  • CLW Basic Materials
  • Exchange
  • ARVN Nasdaq
  • CLW Nasdaq
  • Market Cap
  • ARVN 456.2M
  • CLW 458.4M
  • IPO Year
  • ARVN 2018
  • CLW N/A
  • Fundamental
  • Price
  • ARVN $7.73
  • CLW $29.23
  • Analyst Decision
  • ARVN Buy
  • CLW Buy
  • Analyst Count
  • ARVN 21
  • CLW 1
  • Target Price
  • ARVN $20.53
  • CLW $37.00
  • AVG Volume (30 Days)
  • ARVN 2.1M
  • CLW 168.8K
  • Earning Date
  • ARVN 07-29-2025
  • CLW 08-05-2025
  • Dividend Yield
  • ARVN N/A
  • CLW N/A
  • EPS Growth
  • ARVN N/A
  • CLW 73.65
  • EPS
  • ARVN N/A
  • CLW 10.33
  • Revenue
  • ARVN $426,900,000.00
  • CLW $1,503,000,000.00
  • Revenue This Year
  • ARVN $4.26
  • CLW $15.71
  • Revenue Next Year
  • ARVN N/A
  • CLW $1.44
  • P/E Ratio
  • ARVN N/A
  • CLW $2.63
  • Revenue Growth
  • ARVN 498.74
  • CLW 72.88
  • 52 Week Low
  • ARVN $5.90
  • CLW $22.58
  • 52 Week High
  • ARVN $34.11
  • CLW $57.13
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 50.16
  • CLW 46.45
  • Support Level
  • ARVN $7.09
  • CLW $27.02
  • Resistance Level
  • ARVN $7.89
  • CLW $28.95
  • Average True Range (ATR)
  • ARVN 0.35
  • CLW 0.71
  • MACD
  • ARVN 0.00
  • CLW -0.09
  • Stochastic Oscillator
  • ARVN 38.14
  • CLW 38.85

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: